Home

research lectures

presentations and lectures


Invited Presentations/Meetings

  1. Summary talk - Neuroscience of Diversity symposium –. Organization for Human Brain Mapping Annual Meeting, Rome, Italy, June 2019 - upcoming
  2. OHBM Meet the mentors (invited mentor) –. Organization for Human Brain Mapping Annual Meeting, Rome, Italy, June 2019 - upcoming
  3. Opening talk - Connecting the dots across scales and species in dementia research. Canadian Neuroinformatics Hackathon on Data Modeling and Interoperability, Toronto, May 2019 – upcoming
  4. A multiomics approach to understanding Alzheimer’s disease. University of Toronto, April 2019
  5. A multiomics approach to understanding Alzheimer’s disease. Neurodiscussions – University of Montreal, March 2019
  6. Reliability of multisite resting-state MRI – CCNA Team 9B Meeting, March 2019
  7. Towards reducing the heterogeneity of Alzheimer’s disease using multiomics biomarkers. Institut universitaire de gériatrie de Montréal, Canada, January 2019
  8. A multiomics approach to understanding Alzheimer’s disease. Le Consortium d'Imagerie en Neurosciences et Santé Mentale de Québec, Laval University, Canada, November 2018
  9. A multiomics approach to understanding Alzheimer’s disease. Douglas Cerebral Imaging Centre Lecture Series, Douglas Research Institute, Montreal, November 2018
  10. Interplay between the neurosciences and art. Resting State and Brain Connectivity Meeting, Montreal, Canada, October 2018
  11. Canadian Consortium of Neurodegeneration in Aging (CCNA) trainee society executive summary. CCNA Science Day and Partners Forum, Montreal, Canada, October 2018
  12. Biomarkers – omics to imaging. 18th International Biotechnology Symposium and Exhibition, Montreal, August 2018
  13. Emerging biomarkers in Alzheimer’s disease. Institut du Cerveau et de la Moelle Epinière, Paris, France, July 2018
  14. A multiomics approach to understanding Alzheimer’s disease. University of Nottingham, United Kingdom, July 2018
  15. Impaired neurovascular coupling in Alzheimer’s disease. University of Odense, Denmark, July 2018
  16. Invited Meeting - Aperture workflow meeting. Organization of Human Brain Mapping, Montreal, May 2018
  17. Towards reducing the heterogeneity of Alzheimer’s disease using multiomics biomarkers. Feindel Brain Imaging Centre Lecture Series, Montreal Neurological Institute, Montreal, April 2018
  18. A multidisciplinary approach to understanding Alzheimer’s disease: Insights from proteomics and neuroimaging. Rotman Research Institute Baycrest, Toronto, April 2018
  19. A multidisciplinary approach to understanding Alzheimer’s disease: Insights from proteomics and neuroimaging. Concordia University, Montreal, March 2018
  20. Consistency of resting-state functional MRI connectivity over 2.5 years and 13 sites using the Canadian Dementia Imaging Protocol.
    Badhwar A, Collin-Verreault Y, Orban P, Urchs S, Chouinard I, Vogel J, Potvin O, Duchesne S, Bellec P.
    Canadian Consortium of Neurodegeneration in Aging Science Day, Montreal 2018.
  21. White paper on appropriate analytical and statistical methods for biofluid biomarker context of use – An Update.
    Biofluid based biomarkers Working Group of the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment.
    Alzheimer’s Association International Conference (AAIC), Chicago 2018.
  22. Alzheimer’s Disease: Insights from proteomics and neuroimaging. National Research Council, Ottawa, October 2017
  23. A reproducible, standardized workflow for the generation of fMRI markers of neurodegeneration. Human Brain Mapping Revisited, Montreal 2017
  24. Resting-state network dysfunction in Alzheimer’s disease: Meta-analysis and biotypes. Oxford University, FMRIB Seminar Series, Oxford, England, July 2017
  25. A multimodal approach to understanding Alzheimer’s disease: Insights from proteomics and neuroimaging. Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany, May 2017
  26. Resting-state network dysfunction in Alzheimer’s disease: Meta-analysis and biotypes. Institute of Neuroscience and Medicine, Brain and Behaviour, Research Center Jülich, Germany, May 2017
  27. Resting-State Network Dysfunction in Alzheimer’s disease: A Systematic Review and Meta-Analysis. Feindel Brain Imaging Lecture, Montreal, Canada, February 20, 2017
  28. Neuro Film Series: Mr. Holmes. Montreal Neurological Institute, Montreal, Canada, February 2017
  29. Resting-State Network Dysfunction in Alzheimer’s disease: A Systematic Review and Meta-Analysis. AAIC, Toronto, Canada, July 2016
  30. BrainSwag: Hacking the BrainSpell Interface. Organization for Human Brain Mapping Hackathon, Lausanne, Switzerland, June 2016
  31. Dementia and Art. Brainhack Paris, Paris, France, February 2016
  32. Resting-state functional connectivity genetics. Brainhack Paris, Paris, France, February 2016
  33. Targeting brain plasticity and vascular impairment in Alzheimer’s disease mice. PREVENT-Alzheimer Disease seminar series, Montreal, Canada, September 2015
  34. From cellular neurobiology to complex brain functions... the case of Alzheimer’s disease. University of Montreal (ANT3450 – Neurosciences et Anthropologie), Montreal, Canada, June 2015
  35. Genetics of Alzheimer’s disease. Alzheimer Society of Montreal, Canada, February 2015
  36. Alzheimer’s Disease Imaging. What’s Genes Got To Do, Got To Do With It? Feindel Brain Imaging Center (BIC) Lecture Series, Montreal, Canada, June 2014
  37. Impact of therapeutics on neuroanatomical plasticity and cerebrovascular proteome in Alzheimer’s disease. Centre de recherche de l’IUGM, Montreal, Canada, June 16, 2014
  38. Impaired Structural Correlates of Memory in a Mouse Model of Alzheimer’s Disease. McConnell Brain Imaging Center (BIC) Lecture Series, Montreal, Canada, May 2013
  39. Proteomic differences in brain vessels from Alzheimer’s disease mice and wildtype controls: normalization by PPARγ agonist pioglitazone. Brain and Brain PET, Barcelona, Spain, May 2011
  40. Cerebrovascular proteomics in Alzheimer’s disease. National Research Council - Institute for Biological Sciences Alzheimer’s Research Symposium, Ottawa, Canada, June 2010
  41. Label-free quantitative proteomics of surgically isolated murine brain vessels. National Research Council - Neuroproteomics Group, Ottawa, Canada, April 2010
  42. Canadian Genetic Disease Network 16th Annual Scientific Meeting; Saint Sauveur, Canada, April 2007
  43. Vervet Monkey Genomics. GRID Genome Quebec, Montreal, Canada, November 2006
  44. Canadian Genetic Disease Network 15th Annual Scientific Meeting; Saint Sauveur, Canada, April 2006
  45. Genetics of Joubert syndrome. Joubert Syndrome Foundation: 5th Biennial Conference, Baltimore, July 2000
  46. Myoclonic status epilepticus: video presentation. Myoclonus and Paroxysmal Disorders Meeting; Atlanta, USA, October 2000





 

Home | Artwork | Research | Press | Contact